Renal replacement Therapy in Saskat chewan: A population based analysis

Aim: Chronic kidney disease is a critical condition with considerable public health implications. It affects a significant proportion of the general population and when progressive, has an increasing influence on morbidity and mortality. The main purpose of this study was to explore the distribution and trends of renal replacement therapy and vascular access practice patterns among Saskatchewan end stage renal disease patients.Material and Method: This is a registry-based retrospective observational study. Prevalence of patient’s on renal replacement therapy in the Canadian Organ Replacement Register who has information for renal replacement therapy from 2006 to 2016 in the province of Saskatchewan. The composite of demographics, mortality, type of renal replacement therapy, type of vascular access and important blood markers ranges were recorded among both haemodialysis and peritoneal dialysis patients.Results: From 2006 through 2016, a total of 2103 patients with mean age of 69.52±13.2 initiated renal replacement therapy in Saskatchewan. Among those patients, over half of the patients were female (62%). Majority of the patients were Caucasians and Aboriginals. Nearly two third of them were overweight and obese. Less than half developed end stage renal diseases secondary to diabetes and 14.9% had a primary diagnosis of glomerulonephritis. At the end of 2015, prevalence of end-stage kidney disease patients was 1330 in the Saskatchewan. During 2006 to 2016, 72.3% received haemodialysis, 22.8% received peritoneal dialysis, and, catheter was the most frequently used dialysis access method (64.6%).Conclusion: An increasing number of patients with advanced renal disease are being initiated on long-term dialysis every year. Haemodialysis and peritoneal dialysis are the two main types of dialysis provided under renal care programs. Alarmingly, in Saskatchewan, catheter was the most frequently used dialysis access method.

PDF

___

Ortiz A, Covic A, Fliser D, et al. Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure. Lancet. 2014;383:1831-43.
Canadian Organ Replacement Register, Canadian Institute for Health Information. Available from: https://www.cihi.ca/en/access-data-reports/results?f%5B0%5D=field_primary_theme%3A2056 Online 2017. Last accessed March 2018
Canadian organ replacement register annual report: treatment of end-stage organ failure 2579 in Canada, 2004 to 2013. Ottawa: CIHI. Available from: Online 2015. https://secure.cihi.ca/free_products/2015_CORR_AnnualReport_ENweb.pdf> Last accessed March 2018
Dhoul N, de Lusignan S, Dmitrieva O, et al. Quality achievement and disease prevalence in primary care predicts regional variation in renal replacement therapy (RRT) incidence: an ecological study. Nephrology Dialysis Transplantation 2012;27:739-46.
Korevaar JC, Feith GW, Dekker FW, et al. Effect of starting with hemodialysis compared with peritoneal dialysis in patients new on dialysis treatment: a randomized controlled trial. Kidney Int 2003;64:2222-8.
UK Renal Registry Report. UK Renal Registry 14th Annual Report: Chapter 2 UK RRT Prevalence in 2010: National and centre-specific analyses. UK Renal Registry, Bristol, UK; Queens University, Belfast, UK. 2011.
USRDS (U S Renal Data System). Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD. 2011.
Dumaine C, Kiaii M, Miller L, et al. Vascular access practice patterns in canada: a national survey. Can J Kidney Health Dis 2018;5:2054358118759675.
Report of the canadian society of nephrology vascular access working group. Report of the canadian society of nephrology vascular access working group. Semin Dial. 2012;25:22-5.
Pisoni RL, Zepel L, Port FK, et al. Trends in US Vascular Access Use, Patient Preferences, and Related Practices: An Update From the US DOPPS Practice Monitor With International Comparisons. Am J Kidney Dis 2015;65:905-15.
Hou SH, Bushinsky DA, Wish JB, et al. Hospital-acquired renal insufficiency: a prospective study. Am J Med 1983;74:243-8.
Kaufman J, Dhakal M, Patel B, et al. Community-acquired acute renal failure. Am J Kidney Dis, 1991, 17:191-198. On, sensitivity, and predictability. Am J Kidney Dis 2005;46:1038.
Liano F, Pascual J. Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Madrid Acute Renal Failure Study Group. Kidney Int 1996;50:811-8.
Bakris GL. Recognition, pathogenesis, and treatment of different stages of nephropathy in patients with type 2 diabetes mellitus. Mayo Clin Proc 2011;86:444-56.
Van Buren PN, Toto R. Hypertension in diabetic nephropathy: epidemiology, mechanisms, and management. Adv Chronic Kidney Dis 2011;18:28-41.
Asif A. Reducing the morbidity of tunneled haemodialysis catheters--a symposium. Semin Dial 2008;21:503.
Fluck R, Rao R, Schalkwyk D, et al. The UK Vascular Access Survey – Follow up data and repeat survey (Chapter 5). Nephrol Dial Transplant 2007;22:51-7.
de Jager DJ, Grootendorst DC, Jager KJ, et al. Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA 2009;302:1782-9.
Vogelzang JL, van Stralen KJ, Noordzij M, et al. Mortality from infections and malignancies in patients treated with renal replacement therapy: data from the ERA-EDTA registry. Nephrology Dialysis Transplantation 2015;30:1028-3.